Literature DB >> 21916995

Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.

Kenneth J Vega1, Randal May, Sripathi M Sureban, Stan A Lightfoot, Dongfeng Qu, Alessandra Reed, Nathaniel Weygant, Rama Ramanujam, Rhonda Souza, Mohammad Madhoun, Joshua Whorton, Shrikant Anant, Stephen J Meltzer, Courtney W Houchen.   

Abstract

BACKGROUND AND AIM: In Barrett's esophagus (BE), the normal esophageal squamous epithelium is replaced with a specialized metaplastic columnar epithelium. BE is a premalignant lesion that can progress to esophageal adenocarcinoma (EAC). Currently, there are no early molecular indicators that would predict progression from BE to EAC. As the only permanent residents of the epithelium, stem cells have been implicated in this metaplastic progression. The aim of the present study was to determine the expression of doublecortin and CaM kinase-like-1 (DCAMKL-1) and other putative gastrointestinal stem cell markers in normal esophageal mucosa (NEM), BE, and EAC.
METHODS: Human NEM, BE, EAC, and multitissue microarrays were analyzed for DCAMKL-1, and immunohistochemically scored based on staining intensity and tissue involvement, with epithelia and stroma scored separately. Total RNA isolated from BE and paired NEM was subjected to real-time reverse-transcription-polymerase chain reaction analysis for DCAMKL-1, leucine-rich repeat-containing G-protein-coupled receptor (LGR5), and Musashi-1 (Msi-1) mRNA expression.
RESULTS: DCAMKL-1 was minimally expressed in squamous NEM, but increased in BE (with and without dysplasia) and EAC tissues. In EAC, we found increased stromal DCAMKL-1 staining compared to adjacent epithelia. Within the submucosa of dysplastic BE tissues, an increase in the endothelial cell expression of DCAMKL-1 was observed. Finally, an upregulation of DCAMKL-1, LGR5, and Msi-1 mRNA was seen in BE compared to squamous NEM.
CONCLUSIONS: In the present study, we report the progressive increase of DCAMKL-1 expression in BE from dysplasia to EAC. Furthermore, there was an increase in putative stem cell markers DCAMKL-1, LGR5, and Msi-1 mRNA. Taken together, these data suggest that the regulation of resident stem cells might play an important role in the progression of BE to EAC.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21916995      PMCID: PMC3289765          DOI: 10.1111/j.1440-1746.2011.06928.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  28 in total

1.  DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism.

Authors:  Sripathi M Sureban; Randal May; Stan A Lightfoot; Aimee B Hoskins; Megan Lerner; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Altaf Mohammed; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

Review 2.  Biomarkers in Barrett esophagus.

Authors:  K K Krishnadath; B J Reid; K K Wang
Journal:  Mayo Clin Proc       Date:  2001-04       Impact factor: 7.616

3.  Human Barrett's adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant.

Authors:  Lloyd Hutchinson; Bjorn Stenstrom; Duan Chen; Bilal Piperdi; Sara Levey; Stephen Lyle; Timothy C Wang; JeanMarie Houghton
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

4.  Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreas.

Authors:  Randal May; Sripathi M Sureban; Stan A Lightfoot; Aimee B Hoskins; Daniel J Brackett; Russell G Postier; Rama Ramanujam; Chinthalapally V Rao; James H Wyche; Shrikant Anant; Courtney W Houchen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-03       Impact factor: 4.052

5.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.

Authors:  C Ell; A May; L Gossner; O Pech; E Günter; G Mayer; R Henrich; M Vieth; H Müller; G Seitz; M Stolte
Journal:  Gastroenterology       Date:  2000-04       Impact factor: 22.682

6.  Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers.

Authors:  Brechtje A Grotenhuis; Winand N M Dinjens; Bas P L Wijnhoven; Petra Sonneveld; Andrea Sacchetti; Patrick F Franken; Herman van Dekken; Hugo W Tilanus; J Jan B van Lanschot; Riccardo Fodde
Journal:  J Pathol       Date:  2010-08       Impact factor: 7.996

7.  Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE).

Authors:  James Cronin; Elizabeth McAdam; Antonios Danikas; Chris Tselepis; Paul Griffiths; John Baxter; Linzi Thomas; James Manson; Gareth Jenkins
Journal:  Am J Gastroenterol       Date:  2010-12-14       Impact factor: 10.864

8.  Dysfunctional transforming growth factor-β signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma.

Authors:  Jonathan Mendelson; Shumei Song; Ying Li; Dipen M Maru; Bibhuti Mishra; Marta Davila; Wayne L Hofstetter; Lopa Mishra
Journal:  Cancer       Date:  2011-02-08       Impact factor: 6.860

9.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn.

Authors:  Douglas K Rex; Oscar W Cummings; Michael Shaw; Mark D Cumings; Roy K H Wong; Raj S Vasudeva; Donal Dunne; Emad Y Rahmani; Debra J Helper
Journal:  Gastroenterology       Date:  2003-12       Impact factor: 22.682

10.  LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus?

Authors:  Burkhard H A von Rahden; Stefan Kircher; Maria Lazariotou; Christoph Reiber; Luisa Stuermer; Christoph Otto; Christoph T Germer; Martin Grimm
Journal:  J Exp Clin Cancer Res       Date:  2011-02-23
View more
  34 in total

Review 1.  Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus.

Authors:  Michael Bennett; Hiroshi Mashimo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 2.  Barrett oesophagus: lessons on its origins from the lesion itself.

Authors:  Stuart A C McDonald; Danielle Lavery; Nicholas A Wright; Marnix Jansen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-11-04       Impact factor: 46.802

Review 3.  Dclk1-expressing tuft cells: critical modulators of the intestinal niche?

Authors:  Moritz Middelhoff; C Benedikt Westphalen; Yoku Hayakawa; Kelley S Yan; Michael D Gershon; Timothy C Wang; Michael Quante
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-07-06       Impact factor: 4.052

4.  Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma.

Authors:  Raphael Schellnegger; Anne Quante; Susanne Rospleszcz; Martina Schernhammer; Bettina Höhl; Moritz Tobiasch; Agnieszka Pastula; Anna Brandtner; Julian A Abrams; Konstantin Strauch; Roland M Schmid; Michael Vieth; Timothy C Wang; Michael Quante
Journal:  Cancer Prev Res (Phila)       Date:  2016-11-02

5.  Pancreatic DCLK1+ cells originate distinctly from PDX1+ progenitors and contribute to the initiation of intraductal papillary mucinous neoplasm in mice.

Authors:  Wanglong Qiu; Helen E Remotti; Sophia M Tang; Elizabeth Wang; Lily Dobberteen; Ayman Lee Youssof; Joo Hee Lee; Edwin C Cheung; Gloria H Su
Journal:  Cancer Lett       Date:  2018-03-08       Impact factor: 8.679

6.  Expression of doublecortin and CaM kinase-like-1 protein in serrated neoplasia of the colorectum.

Authors:  Keiko Morio; Kazuo Yashima; Akihiro Tamoto; Kohei Hosoda; Sohei Yamamoto; Taku Iwamoto; Naoki Ueda; Yuichiro Ikebuchi; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki; Hajime Isomoto
Journal:  Biomed Rep       Date:  2017-11-10

Review 7.  Barrett esophagus: what a mouse model can teach us about human disease.

Authors:  Michael Quante; Julian A Abrams; Yoomi Lee; Timothy C Wang
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

Review 8.  APSA Awardee Submission: Tumor/cancer stem cell marker doublecortin-like kinase 1 in liver diseases.

Authors:  Charles B Nguyen; Courtney W Houchen; Naushad Ali
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

9.  DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.

Authors:  Tianbo Gao; Min Wang; Lingling Xu; Tao Wen; Jian Liu; Guangyu An
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-12       Impact factor: 4.553

10.  Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line.

Authors:  Lianna Li; Charles F Bellows
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.